share_log

翰森製藥:致非登記持有人之通知信函及申請表格

HANSOH PHARMA: Notification Letter and Request Form to Non-registered Holders

HKEX ·  Sep 26, 2024 16:56

Summary by Moomoo AI

翰森製藥集團有限公司於2024年9月27日向非登記持有人發出通知,公告其2024年中期報告已可在公司及香港聯合交易所有限公司網站上獲得。公司鼓勵股東透過網站閱讀中期報告及未來所有公司通訊。對於無法接收電子通訊的股東,公司提供了印刷版報告的申請方式,並承諾免費提供。此外,公司亦指出,若股東希望以電子形式接收公司通訊,應通過其股份代理機構提供電子郵件地址。公司將只在收到有效電郵地址前,以印刷形式發送通訊。
翰森製藥集團有限公司於2024年9月27日向非登記持有人發出通知,公告其2024年中期報告已可在公司及香港聯合交易所有限公司網站上獲得。公司鼓勵股東透過網站閱讀中期報告及未來所有公司通訊。對於無法接收電子通訊的股東,公司提供了印刷版報告的申請方式,並承諾免費提供。此外,公司亦指出,若股東希望以電子形式接收公司通訊,應通過其股份代理機構提供電子郵件地址。公司將只在收到有效電郵地址前,以印刷形式發送通訊。
hansoh pharma group limited issued a notice to non-registered holders on September 27, 2024, announcing that its mid-year report for 2024 is available on the company's website and the Hong Kong Stock Exchange's website. The company encourages shareholders to read the mid-year report and all future company communications through the website. For shareholders who cannot receive electronic communications, the company provides a way to apply for a printed version of the report free of charge. In addition, the company also notes that shareholders wishing to receive company communications electronically should provide their email address through their share registrar institutions. The company will only send communications in printed form until a valid email address is received.
hansoh pharma group limited issued a notice to non-registered holders on September 27, 2024, announcing that its mid-year report for 2024 is available on the company's website and the Hong Kong Stock Exchange's website. The company encourages shareholders to read the mid-year report and all future company communications through the website. For shareholders who cannot receive electronic communications, the company provides a way to apply for a printed version of the report free of charge. In addition, the company also notes that shareholders wishing to receive company communications electronically should provide their email address through their share registrar institutions. The company will only send communications in printed form until a valid email address is received.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more